Next Article in Journal
Sugar Beet Pectin Supplementation Did Not Alter Profiles of Fecal Microbiota and Exhaled Breath in Healthy Young Adults and Healthy Elderly
Next Article in Special Issue
Urinary Taurine Excretion and Risk of Late Graft Failure in Renal Transplant Recipients
Previous Article in Journal
Breastfeeding Disparities between Multiples and Singletons by NICU Discharge
Open AccessArticle

Comparing the Effect of Folic Acid and Pentoxifylline on Delaying Dialysis Initiation in Patients with Advanced Chronic Kidney Disease

1
Department of Nephrology, Department of Internal Medicine, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung 427, Taiwan
2
Department of Medical Research, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung 427, Taiwan
3
Division of Gastroenterology, Department of Internal Medicine, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung 427, Taiwan
4
School of Medicine, Tzu Chi University, Hualien 970, Taiwan
5
Graduate Institute of Integrated Medicine, China Medical University, Taichung 404, Taiwan
6
Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei 112, Taiwan
*
Author to whom correspondence should be addressed.
Nutrients 2019, 11(9), 2192; https://doi.org/10.3390/nu11092192
Received: 8 July 2019 / Revised: 4 September 2019 / Accepted: 7 September 2019 / Published: 12 September 2019
(This article belongs to the Special Issue Nutrition and Chronic Kidney Disease (CKD))
Background: We hypothesized that the nutrient loss and chronic inflammation status may stimulate progression in advanced chronic kidney disease. Therefore, we aimed to generate a study to state the influence of combined nutritional and anti-inflammatory interventions. Methods: The registry from the National Health Insurance Research Database in Taiwan was searched for 20–90 years individuals who had certified end-stage renal disease. From January 2005 through December 2010, the diagnosis code ICD-9 585 (chronic kidney disease, CKD) plus erythropoiesis-stimulating agent (ESA) use was defined as entering advanced chronic kidney disease. The ESA starting date was defined as the first index date, whereas the initiation day of maintenance dialysis was defined as the second index date. The duration between the index dates was analyzed in different medical treatments. Results: There were 10,954 patients analyzed. The combination therapy resulted in the longest duration (n = 2184, median 145 days, p < 0.001) before the dialysis initiation compared with folic acid (n = 5073, median 111 days), pentoxifylline (n = 1119, median 102 days, p = 0.654), and no drug group (control, n = 2578, median 89 days, p < 0.001). Lacking eGFR data and the retrospective nature are important limitations. Conclusions: In patients with advanced CKD on the ESA treatment, the combination of folic acid and pentoxifylline was associated with delayed initiation of hemodialysis. View Full-Text
Keywords: angiotensin-converting enzyme inhibitor; angiotensin receptor blocker; chronic kidney disease; delay dialysis; erythropoiesis-stimulating agent; folic acid; pentoxifylline angiotensin-converting enzyme inhibitor; angiotensin receptor blocker; chronic kidney disease; delay dialysis; erythropoiesis-stimulating agent; folic acid; pentoxifylline
Show Figures

Figure 1

MDPI and ACS Style

Yang, H.; Juang, S.-Y.; Liao, K.-F.; Chen, Y.-H. Comparing the Effect of Folic Acid and Pentoxifylline on Delaying Dialysis Initiation in Patients with Advanced Chronic Kidney Disease. Nutrients 2019, 11, 2192.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map

1
Back to TopTop